/
EVH
$5.77+$0.26 (+4.72%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$619.8M
112M shares
52-week range
$2.10 – $12.07
37% from low
Sector
SERVICES-MANAGEMENT SERVICES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-15.35
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $627.1M | $687.1M | $924.6M | $908.0M | $1.35B | $1.96B | $2.55B | $1.88B |
| Cost of revenue | $327.8M | $513.0M | $696.6M | $657.6M | $1.04B | $1.50B | $2.19B | $1.59B |
| Gross profit | $299.2M | $174.1M | $228.1M | $250.4M | $316.6M | $460.5M | $367.4M | $284.0M |
| Gross margin | 47.7% | 25.3% | 24.7% | 27.6% | 23.4% | 23.4% | 14.4% | 15.1% |
| R&D | $18.2M | $0 | $0 | $0 | $27.0M | $0 | $0 | $0 |
| Operating income | −$47.5M | −$308.9M | −$262.8M | −$42.4M | $3.6M | −$71.2M | −$40.5M | −$4.4M |
| EBITDA | −$4.2M | −$254.5M | −$240.7M | $55.7M | $43.7M | −$24.8M | $84.9M | −$361.3M |
| Net income | −$52.7M | −$302.0M | −$334.2M | −$37.6M | −$19.2M | −$113.0M | −$61.6M | −$534.5M |
| Net margin | -8.4% | -43.9% | -36.1% | -4.1% | -1.4% | -5.8% | -2.4% | -28.5% |
| EPS (diluted) | -0.68 | -3.71 | -3.94 | -0.36 | -0.20 | -1.28 | -0.81 | -5.07 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.5B | $0.18 | $0.14–$0.21 | 7 |
| 2027 | $3.0B | $0.37 | $0.35–$0.37 | 8 |
| 2028 | $3.4B | $0.49 | $-0.16–$1.03 | 5 |
| 2029 | $4.1B | $0.70 | $0.65–$0.75 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Evolent Health, Inc Class A Common Stock
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
www.evolenthealth.com- Employees
- 4,200
- IPO / List date
- Jun 5, 2015
- HQ
- ARLINGTON, VA
Held by traders on TradeandTell
No one on the platform currently holds EVH.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 174,599 | $698.4K |
| Bridgewater Associatesas of 2024-12-31 | 21,118 | $237.6K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded EVH yet.
